Get started
INOVIO PHARMACEUTICALS INC COM USD0.001(POST SPLIT)INOVIO PHARMACEUTICALS INC COM USD0.001(POST SPLIT)INOVIO PHARMACEUTICALS INC COM USD0.001(POST SPLIT)

INOVIO PHARMACEUTICALS INC COM USD0.001(POST SPLIT)

No trades
See on Supercharts
Overview
Financials
News Discussions Technicals Forecast Seasonals

0A43 fundamentals

Key facts

Market capitalization—
Dividend yield (indicated)—
Price to earnings Ratio (TTM)—
Basic EPS (TTM)—
Founded—
Employees (FY)—
CEO—
Website—
About

Inovio Pharmaceuticals, Inc. engages in the provision of designed DNA medicines to treat and protect people from infectious diseases, cancer, and diseases associated with human papillomavirus. Its product pipeline includes VGX-3100, INO-3107, INO-5410, INO-4800, and PENNVAX-GP. The company was founded by David B. Weiner on June 29, 1983 and is headquartered in Plymouth Meeting, PA.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

0A43 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company